格隆汇8月1日丨牧原股份(002714.SZ)公布，截至2025年7月31日，公司通过股份回购专用证券账户以集 中竞价方式累计回购公司股份5,363.12万股，占公司目前总股本的0.98%，最高成交价为46.20元/股，最 低成交价为36.16元/股，成交总额为21.597亿元(不含交易费用)。 ...

一、回购公司股份的进展情况 公司于 2024 年 10 月 18 日通过股份回购专用证券账户以集中竞价方式首次 | 证券代码：002714 | 证券简称：牧原股份 | 公告编号：2025-071 | | --- | --- | --- | | 债券代码：127045 | 债券简称：牧原转债 | | 牧原食品股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 牧原食品股份有限公司（以下简称"公司"）于 2024 年 9 月 25 日召开的第 四届董事会第二十九次会议审议通过了《关于回购公司股份的议案》，公司拟使 用自有资金或自筹资金以集中竞价交易的方式回购公司发行的人民币普通股（A 股），回购总金额不低于人民币 30 亿元且不超过人民币 40 亿元（均含本数），回 购价格不超过人民币 58.60 元/股（含本数）。由于公司实施权益分派，于 2025 年 6 月 26 日调整回购股份价格为不超过人民币 57.22 元/股（含本数）。本次调整后， 按回购金额上限人民币 40 亿元、回购价格上限 57.22 元/股测算，预计可回购 ...

牧原食品股份有限公司 关于向专业投资者公开发行公司债券获得 中国证监会注册批复的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 牧原食品股份有限公司（以下简称"公司"）于近日收到中国证券监督管理 委员会于2025年7月25日出具的《关于同意牧原食品股份有限公司向专业投资者 公开发行公司债券注册的批复》（证监许可〔2025〕1564号），批复主要内容如 下： 一、同意公司向专业投资者公开发行面值总额不超过50亿元公司债券的注册 申请。 | 证券代码：002714 | 证券简称：牧原股份 公告编号：2025-072 | | --- | --- | | 债券代码：127045 | 债券简称：牧原转债 | 三、批复自同意注册之日起24个月内有效，公司在注册有效期内可以分期发 行公司债券。 四、自同意注册之日起至本次公司债券发行结束前，公司如发生重大事项， 应及时报告并按有关规定处理。 公司将按照有关法律法规和上述批复文件的要求及公司股东大会的授权办 理本次公司债券发行的相关事宜，并及时履行信息披露义务。 特此公告。 牧原食品股份有限公司 董 事 会 2025年8 ...

格隆汇8月1日｜牧原股份公告，公司于近日收到中国证券监督管理委员会于2025年7月25日出具的《关 于同意牧原食品股份有限公司向专业投资者公开发行公司债券注册的批复》，证监会同意公司向专业投 资者公开发行面值总额不超过50亿元公司债券的注册申请。批复自同意注册之日起24个月内有效，公司 在注册有效期内可以分期发行公司债券。 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300313 | *ST天山 | 9.67 | -3.30% | 7.49万 | 7319.70万 | | 002714 | 牧原股份 | 45.81 | -1.19% | 29.85万 | 13.76亿 | | 002458 | 益生股份 | 8.78 | -0.90% | 10.62万 | 9390.65万 | | 002299 | 圣农发展 | 15.82 | -0.88% | 10.59万 | 1.68亿 | | 605296 | 神农集团 | 31.73 | -0.84% | 2.63万 | 8431.63万 | | 000735 | 罗牛山 | 6.29 | -0.47% | 20.62万 | 1.30亿 | | 603477 | 巨星农牧 | 20.60 | -0.43% | 9.84万 | 2.04亿 | | 002157 | 正邦科技 | 2.82 | -0.35% | 61.28万 | 1.74亿 | | 000876 | 新希 ...

Core Viewpoint - The A-share market showed a strong recovery in July, with all 30 broker stock combinations recorded positive returns, indicating a favorable investment environment [1][4]. Group 1: July Stock Performance - The top-performing stock in July was Kangchen Pharmaceutical, recommended by Ping An Securities, with a remarkable increase of 106.74% [3][4]. - Other notable stocks included Bori Pharmaceutical (82.05% increase) and Kangfang Biotech (68.13% increase), recommended by Dongwu Securities and Northeast Securities respectively [3][4]. - Stocks such as Yuandong Biological, Dongshan Precision, and Jitu Express-W also saw increases exceeding 50% [4]. Group 2: Broker Performance - Ping An Securities led the broker stock combinations with a return of 16.57% in July, followed by Kaiyuan Securities (13.57%) and Caitong Securities (12.93%) [5]. - Other brokers like China Merchants Securities, Great Wall Securities, and Galaxy Securities also achieved returns above 10% [5]. Group 3: August Investment Strategy - Brokers are adopting an aggressive strategy for August, focusing on technology growth stocks and cyclical stocks benefiting from mid-year performance [7][11]. - The market is expected to continue its upward trend driven by optimistic expectations regarding corporate ROE recovery [11]. Group 4: Recommended Stocks for August - The most frequently recommended stocks for August include Dongfang Caifu, Muyuan Foods, and Wanhua Chemical, each receiving four recommendations from different brokers [13][14]. - Dongfang Caifu is expected to benefit from a bullish trend in the securities sector, while Muyuan Foods is projected to maintain stable profits amid rising pig prices [13][14].

金十图示：2025年08月01日（周五）富时中国A50指数成分股今日收盘行情一览：银行股走势分化，石油、证券、医药股走软 富时中国A50指数连续 光大银行 2392.96亿市值 6.38亿成交额 4.05 0.00(0.00%) 保险 中国太保 中国平安 中国人保 机械 3608.68亿市值 3569.15亿市值 10598.36亿市值 9.02亿成交额 28.60亿成交额 6.15亿成交额 58.20 37.10 8.16 -0.36(-0.96%) -0.49(-0.83%) -0.02(-0.24%) 酿酒行业 贵州茅台 山西汾酒 五粮液 17800.32亿市值 2182.64亿市值 4696.75亿市值 42.01亿成交额 9.39亿成交额 14.91亿成交额 1417.00 178.91 121.00 -4.67(-0.33%) -0.09(-0.05%) -0.15(-0.12%) 半导体 海光信息 北方华创 寒武纪-U HYGON 2379.85亿市值 2882.85亿市值 3201.78亿市值 49.98亿成交额 18.35亿成交额 31.52亿成交额 329.80 689.10 137.75 ...

Group 1 - The overall performance of brokerage "gold stocks" in July was positive, with all 30 brokerage combinations showing gains [2][4] - Ping An Securities' gold stock combination led with a return of 16.57%, followed by Kaiyuan Securities at 13.57% and Caitong Securities at 12.93% [4][5] - The top-performing individual stock was Kangchen Pharmaceutical, recommended by Ping An Securities, which saw a remarkable increase of 106.74% in July [2][3] Group 2 - Other notable stocks included Bori Pharmaceutical with an 82.05% increase and Kangfang Biotech with a 68.13% increase, both recommended by East Wu Securities and Northeast Securities respectively [2][3] - Stocks recommended by Ping An Securities, such as Yuandong Biological, also performed well, with increases exceeding 50% [2] - As of August 1, several brokerages, including Guojin Securities and Guohai Securities, have launched their gold stock combinations for August, focusing on technology growth stocks and cyclical stocks benefiting from mid-year performance [6] Group 3 - The most frequently recommended stocks for August included Dongfang Caifu, Muyuan Foods, and Wanhua Chemical, each receiving four recommendations from different brokerages [9][11] - Guohai Securities highlighted Dongfang Caifu's potential for a significant upward trend in the securities sector over the next two months [10] - Guojin Securities emphasized Muyuan Foods' leading position in pig farming, projecting stable profits amid rising pork prices [10]

Core Viewpoint - The article highlights the strong performance of brokerage "gold stocks" in July, with all 30 brokerage gold stock combinations showing positive returns, indicating a robust recovery in the A-share market [2][9]. Brokerage Performance - Ping An Securities' gold stock combination achieved the highest return of 16.57% in July, followed by Kaiyuan Securities at 13.57% and Caitong Securities at 12.93% [3][9][10]. - Notably, all brokerage gold stock combinations recorded positive returns, with several brokerages, including China Merchants Securities and Galaxy Securities, also exceeding 10% returns [9][10]. Top Performing Stocks - The best-performing stock was Kangchen Pharmaceutical, recommended by Ping An Securities, which surged by 106.74% in July [4][6]. - Other notable stocks included Borui Pharmaceutical (82.05%), Kangfang Biotech (68.13%), and Yuandong Biotech (56.60%), all showing significant monthly gains [6][7]. August Strategy - Brokerages are adopting an aggressive strategy for August, focusing on technology growth stocks and cyclical stocks benefiting from mid-year performance reports [12][15]. - The market outlook is optimistic, driven by expectations of recovering corporate ROE and a favorable policy environment, suggesting a continued upward trend in A-shares [15]. Common Recommendations - Several stocks received multiple recommendations from brokerages for August, including Dongfang Caifu, Muyuan Foods, and Wanhua Chemical, each recommended by four different brokerages [16][19]. - The rationale for recommending Dongfang Caifu includes the potential for the securities sector to enter a main upward trend, while Muyuan Foods is recognized for its leading position in the pig farming industry [16][19].

Quantitative Models and Construction - **Model Name**: "Kaiyuan JinGong Optimal Stock Portfolio" **Model Construction Idea**: This model is based on the observation that newly recommended stocks ("newly entered stocks") outperform repeatedly recommended stocks ("repeated stocks"). It incorporates the "Surprise in Earnings" (SUE) factor to select stocks with strong earnings surprises, aiming to enhance portfolio returns[23][25]. **Model Construction Process**: 1. Use newly recommended stocks as the sample universe. 2. Select the top 30 stocks with the highest SUE factor values. 3. Weight the portfolio based on the number of recommendations by brokers. **Model Evaluation**: The model demonstrates superior performance compared to the overall stock portfolio and benchmark indices, indicating its effectiveness in capturing excess returns[23][25]. Model Backtesting Results - **Kaiyuan JinGong Optimal Stock Portfolio**: - **July Return**: 5.8%[25] - **2025 YTD Return**: 18.0%[25] - **Annualized Return**: 20.8%[25] - **Annualized Volatility**: 25.2%[25] - **Sharpe Ratio (Return-to-Volatility)**: 0.82[25] - **Maximum Drawdown**: 24.6%[25] - **Overall Stock Portfolio**: - **July Return**: 7.7%[21] - **2025 YTD Return**: 18.5%[21] - **Annualized Return**: 12.2%[21] - **Annualized Volatility**: 23.4%[21] - **Sharpe Ratio (Return-to-Volatility)**: 0.52[21] - **Maximum Drawdown**: 42.6%[21] - **Benchmark Indices**: - **CSI 300**: - **July Return**: 3.5%[21] - **2025 YTD Return**: 3.6%[21] - **Annualized Return**: 2.4%[21] - **Annualized Volatility**: 21.2%[21] - **Sharpe Ratio (Return-to-Volatility)**: 0.11[21] - **Maximum Drawdown**: 40.6%[21] - **CSI 500**: - **July Return**: 5.3%[21] - **2025 YTD Return**: 8.7%[21] - **Annualized Return**: 0.1%[21] - **Annualized Volatility**: 23.7%[21] - **Sharpe Ratio (Return-to-Volatility)**: 0.01[21] - **Maximum Drawdown**: 37.5%[21] Quantitative Factors and Construction - **Factor Name**: Surprise in Earnings (SUE) Factor **Factor Construction Idea**: The SUE factor measures the degree of earnings surprise, which is a key indicator of stock performance. Stocks with higher earnings surprises are expected to outperform[23]. **Factor Construction Process**: 1. Calculate the earnings surprise for each stock based on the difference between actual and expected earnings. 2. Rank stocks by their SUE values. 3. Select the top stocks with the highest SUE values for portfolio inclusion[23]. **Factor Evaluation**: The SUE factor demonstrates strong stock selection ability, particularly within the newly recommended stock universe, contributing to the superior performance of the optimal stock portfolio[23]. Factor Backtesting Results - **SUE Factor**: - Integrated into the "Kaiyuan JinGong Optimal Stock Portfolio," contributing to its superior performance metrics as detailed above[23][25].